Alpharma Inc. Adopts Rights Plan to Thwart King Pharmaceuticals®, Inc. Bid

September 2, 2008 |

1 min read

NEW YORK, Sept 2 (Reuters) - Alpharma Inc adopted a short-term shareholder rights plan to thwart a $1.4 billion takeover bid by King Pharmaceuticals Inc, the company said on Tuesday.

Mergers & acquisitions

MORE ON THIS TOPIC

Shanghai.China-Feb.25th 2022: Pfizer company sign on office building. Pharmaceutical and biotechnology corporation

Obesity

After Metsera Battle, Pfizer Heads to China for Another Obesity Deal Worth up to $1.9B

December 9, 2025

·

2 min read

·

Dan Samorodnitsky

Aircrafts landing and taking off at airport by night - vector illustration

Venture capital

Lilly, Novo GLP-1 Pricing Plans Clear Runway For Future Competitors

December 3, 2025

·

2 min read

·

Annalee Armstrong

Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.

Gene editing

Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD

December 1, 2025

·

1 min read

·

Tristan Manalac

Business partners run with big arrow in different directions. Conflict, choice right way business development. Team leadership competition. Quarrel, battle and problems. Flat vector illustration

Mergers & acquisitions

Avidity Played Hardball To Land Favorable Terms in $12B Novartis Deal

November 25, 2025

·

3 min read

·

Annalee Armstrong